Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

ImmunoGen Inc (NASDAQ:IMGN)

During the Trading Day
13.46 +0.48 / +3.70%
As of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
12.98 -0.48 / -3.57%
 
Volume: 26.4K

Today’s Trading

Previous close12.98
Today’s open13.25
Day’s range13.12 - 13.65
Volume888,878
Average volume (3 months)1,391,615
Market cap$1.1B
Dividend yield--
Data as of 3:59pm ET, 09/02/2015

Growth & Valuation

Earnings growth (last year)+14.46%
Earnings growth (this year)-100.66%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)+42.82%
P/E ratioNM
Price/Sales14.46
Price/Book32.01

Competitors

 Today’s
change
Today’s
% change
ATRAAtara Biotherapeutic...+4.13+10.58%
ESPREsperion Therapeutic...+2.05+4.37%
AXONAxovant Sciences Ltd+0.89+7.24%
CHRSCoherus BioSciences ...+0.73+2.71%
Data as of 4:00pm ET, 09/02/2015

Financials

Next reporting dateOctober 23, 2015
EPS forecast (this quarter)-$0.35
Annual revenue (last year)$85.5M
Annual profit (last year)-$60.7M
Net profit margin-71.01%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Daniel M. Junius
Chief Financial Officer &
Executive Vice President
David B. Johnston
Corporate headquarters
Waltham, Massachusetts

Forecasts

Partner Offers